AFFINIA THERAPEUTICS Trademark

Trademark Overview

On Tuesday, January 30, 2024, a trademark application was filed for AFFINIA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the AFFINIA THERAPEUTICS trademark a serial number of 98383245. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Tuesday, July 22, 2025. This trademark is owned by Affinia Therapeutics Inc.. The AFFINIA THERAPEUTICS trademark is filed in the Personal, Legal & Social Services category with the following description:

Licensing of pharmaceutical intellectual property rights concerning a library of adeno-associated virus (AAV) vectors, protein sequences, nucleic acid sequences, and viral capsids for use in the research and development of gene therapy products and treatment; none of the foregoing in the field of analysis and treatment of tumor associated antigens utilizing immune cells
affinia therapeutics

General Information

Serial Number98383245
Word MarkAFFINIA THERAPEUTICS
Filing DateTuesday, January 30, 2024
Status680 - APPROVED FOR PUBLICATION
Status DateTuesday, July 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesLicensing of pharmaceutical intellectual property rights concerning a library of adeno-associated virus (AAV) vectors, protein sequences, nucleic acid sequences, and viral capsids for use in the research and development of gene therapy products and treatment; none of the foregoing in the field of analysis and treatment of tumor associated antigens utilizing immune cells
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 22, 2025
Primary Code045
First Use Anywhere DateTuesday, April 14, 2020
First Use In Commerce DateTuesday, April 14, 2020

Trademark Owner History

Party NameAffinia Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453

Trademark Events

Event DateEvent Description
Tuesday, January 30, 2024NEW APPLICATION ENTERED
Thursday, May 30, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 7, 2024NON-FINAL ACTION WRITTEN
Saturday, September 7, 2024NON-FINAL ACTION E-MAILED
Monday, December 9, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, August 23, 2024ASSIGNED TO EXAMINER
Saturday, September 7, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 9, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, February 6, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, February 6, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 6, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 10, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 10, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 12, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 12, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 6, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 10, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 12, 2025ASSIGNED TO LIE
Tuesday, April 22, 2025FINAL REFUSAL WRITTEN
Tuesday, April 22, 2025FINAL REFUSAL E-MAILED
Tuesday, April 22, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, July 22, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 22, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, July 22, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 22, 2025APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

therapeutics affinia sequences treatment associated cells immune products therapy development gene none